Eguchi K, Kawakami A, Nakashima M, Ida H, Sakito S, Sakai M, Terada K, Kawabe Y, Fukuda T, Ishikawa N
First Department of Internal Medicine, Nagasaki University School of Medicine, Japan.
Acta Endocrinol (Copenh). 1993 Mar;128(3):215-20. doi: 10.1530/acta.0.1280215.
We investigated whether a potent vasoconstrictor, endothelin, stimulated the proliferation of human thyroid epithelial cells (thyrocytes). [3H]-thymidine incorporation into normal thyrocytes and thyrocytes from patients with Graves' disease was significantly increased at 10(-9) mol/l endothelin, reaching a plateau at 10(-8) mol/l. The proliferative responses of the thyrocytes obtained from patients with Graves' disease were similar to those of normal thyrocytes. Furthermore, the cell number of thyrocytes stimulated by endothelin was increased as compared with that of unstimulated thyrocytes. Neither indomethacin nor heparin affected this endothelin-stimulated thyrocyte proliferation. When thyrocytes were cultured with both endothelin and recombinant interleukin 1 beta, there was an additive effect on thyrocyte proliferation. The Ca2+ entry blocker, verapamil, inhibited both the proliferative responses of thyrocytes to endothelin and the additive effect of endothelin and recombinant interleukin 1 beta on thyrocyte proliferation. These results suggest that endothelin functions as a growth-promoting factor for human thyrocytes, presumably through intracellular calcium influx.
我们研究了一种强效血管收缩剂内皮素是否能刺激人甲状腺上皮细胞(甲状腺细胞)的增殖。在10^(-9)摩尔/升的内皮素作用下,[3H]胸腺嘧啶核苷掺入正常甲状腺细胞和格雷夫斯病患者的甲状腺细胞中的量显著增加,在10^(-8)摩尔/升时达到平台期。格雷夫斯病患者的甲状腺细胞的增殖反应与正常甲状腺细胞相似。此外,与未受刺激的甲状腺细胞相比,内皮素刺激的甲状腺细胞数量增加。消炎痛和肝素均不影响内皮素刺激的甲状腺细胞增殖。当甲状腺细胞与内皮素和重组白细胞介素1β共同培养时,对甲状腺细胞增殖有相加作用。钙离子通道阻滞剂维拉帕米既抑制甲状腺细胞对内皮素的增殖反应,也抑制内皮素和重组白细胞介素1β对甲状腺细胞增殖的相加作用。这些结果表明,内皮素可能通过细胞内钙内流,作为人甲状腺细胞的生长促进因子发挥作用。